All News

Patient-centered outcomes research makes pharmacists even more important members of the healthcare team

As you fill the Rx for that "little blue pill," use the opportunity to tell patients that ED can be a precursor of heart disease

Six steps compounding pharmacies can take to create and maintain a culture of quality assurance

"Compounders" and "compounding manufacturers" defined

Approval requires canagliflozin manufacturer to complete five post-marketing studies

Through patient education and screening processes, pharmacists can identify and support underserved patients with mental illness

Drug Topics readers weigh in

FDA asks stakeholders to weigh in on solutions

How can health systems simultaneously improve population health and patient satisfaction, yet reduce per capita costs? A Walgreens model points the way.

For the third consecutive year, Walgreens is partnering with Greater Than AIDS and local health departments across the country to provide free HIV testing between June 27 and June 29.

Reports and presentations made during the Accreditation Council for Pharmacy Education’s Advancing Quality in Pharmacy Education: Charting Accreditation’s Future Conference last year are available online.

Sagent Pharmaceuticals, Inc., Schaumburg, Ill., on June 11 announced a voluntary nationwide recall of three lots of vecuronium bromide for injection 10 mg (NDC number 25021-657-10).

Despite being considered a protected class of drugs, anticonvulsant medications for the treatment of epileptic seizures had lower levels of coverage for Medicare prescription drug plans (PDPs) than commercial health plans.

Unsafe injections remain a problem in the United States and throughout the world, according to a recent Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.

The Obama administration on Monday abandoned its attempt to restrict access to the emergency contraceptive Plan B One-Step (Teva Women’s Health Inc.) as an over-the-counter medication-a decision that’s being celebrated by some groups.

Fruth Pharmacy, an independent chain of pharmacies with 25 stores in West Virginia and Ohio, has launched a mobile app to help its customers manage prescriptions.

Aceto Corporation, Port Washington, N.Y., announced June 11 that its generics subsidiary, Rising Pharmaceuticals Inc., Paramus, N.J., will launch the 50-mg strength of riluzole tablets.

Older adults with diabetes mellitus may be at increased risk for Alzheimer’s disease or vascular dementia following a hypoglycemic event, according to a study published online by JAMA Internal Medicine on June 10th.

Faced with a 68-year-old woman undergoing chemotherapy for breast cancer that had spread to her lungs, chest, and spine, more than three quarters of doctors surveyed recently by the New England Journal of Medicine said they’d prescribe medical marijuana.

The Men’s Health Network is hoping actor Michael Douglas’ assertion that his throat cancer was caused by human papillomavirus contracted during oral sex will provoke more males to get the HPV vaccine.

The National Association of Chain Drug Stores Foundation today announced the second group of pharmacists accepted into its yearlong Faculty Scholars Program.

FDA has approved a new indication for lenalidomide (Revlimid, Celgene) for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.

A federal court in New Jersey has entered a consent judgment regarding the patent infringement litigation between Hanmi Pharmaceuticals (Seoul, Korea) and AstraZeneca (London).

FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to its MedWatch program.

Endometrial cancer patients reduced their chance of death by 84% with the use of statins and aspirin, according to a new study by researchers at Montefiore Einstein Center for Cancer Care.

In a phase 3 study of previously treated patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer, crizotinib (Xalkori, Pfizer) more than doubled median progression free survival than when treated with standard chemotherapy, according to a study published June 1, 2013 online in New England Journal of Medicine.

An audit of two electronic prescribing systems found frequent system-related errors. But the audit, published online in the Journal of the American Medical Informatics Association, found that only a small percentage of those errors were serious and that e-PS prevent more errors than they create.